🇺🇸 FDA
Patent

US 8349353

Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

granted A61KA61K31/00A61K9/0046

Quick answer

US patent 8349353 (Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/00, A61K9/0046